Checchi Capital Advisers’s Charles River Laboratories CRL Stock Holding History

Checchi Capital Advisers’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-503	Closed	-$208K	–	545
2021 Q3	$208K	Sell	503 -500	-50%	-$208K	0.02%	477
2021 Q2	$371K	Sell	1,003 -83	-8%	-$27.7K	0.04%	306
2021 Q1	$315K	Buy	+1,086	New	+$302K	0.03%	342
2016 Q3	–	Sell	-190	Closed	-$16K	–	581
2016 Q2	$16K	Buy	190 +27	+17%	+$2.22K	﹤0.01%	1206
2016 Q1	$12K	Buy	+163	New	+$12.1K	﹤0.01%	1277

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Checchi Capital Advisers's CRL Position: Q4 2021 in Review

Checchi Capital Advisers sold out of Charles River Laboratories (CRL) in Q4 2021, closing a stake of 503 shares — an estimated $208K sold.

Checchi Capital Advisers first reported a position in CRL in Q1 2016 and held it in 5 quarters. The position peaked at $371K in Q2 2021. 707 funds tracked by Wall St. Rank hold CRL as of Q4 2021.

Checchi Capital Advisers reported no remaining Charles River Laboratories position as of Q4 2021 after selling out during the quarter.
Checchi Capital Advisers sold 503 Charles River Laboratories shares in Q4 2021, an estimated $208K.
Checchi Capital Advisers first reported a position in Charles River Laboratories in Q1 2016 and held it in 5 quarters.
Checchi Capital Advisers's Charles River Laboratories position peaked at $371K in Q2 2021.
707 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2021.

Based on Checchi Capital Advisers's 13F filing for Q4 2021, filed 9 Feb 2022.